Predictive Compliance Risk
and Quality Management

A New Digital Paradigm for the Post-COVID-19 World

An FDAnews FREE Webinar • Sponsored by Xybion
Wednesday, July 15, 2020 • 11:00 a.m. - 12:00 p.m. EDT

COVID-19 has exerted pressure on the pharmaceutical industry to create many things digital, including quality and compliance operating systems.

In this free webinar, Pradip K. Banerjee, Ph.D., Xybion’s chairman of the board and chief executive officer, will explain how you can benefit from predictive compliance and make better, more-informed decisions and be proactive, not reactive.

Using a big pharma case study, Dr. Banerjee will show a clear path forward to predictive compliance with risk-prediction software, benchmarking and implementing new robotic process automation software cloud platform using AI and machine learning algorithms. The ROI can be significant, making major improvements to compliance performance levels and result in significant savings, as well as avoiding future penalties and fines. All while keeping your employees healthy and safe.

Webinar Takeaways:

  • How to move your company’s compliance risk and quality management processes into the cloud with full integration with the operating systems
  • How to create a strategic digital future workplace with proactive automated real-time compliance monitoring, AI-driven compliance risk prediction and mitigation to enable continuous data integrity and eChain of custody of information in real time
  • How to improve informed executive decisionmaking by implementing compliance risk management

Be proactive: chart a strategic digital future workplace to maintain data integrity and quickly bring product to market with full regulatory compliance. Join us by registering today for this free webinar.

Who Will Benefit

  • CEOs of biotech companies with advanced pipelines
  • Senior Compliance Leaders of pharmaceutical companies and generic drugmakers
  • Senior Vice President of Regulatory Affairs and Compliance, Risk Management and Quality
  • CIOs of pharmaceutical and biotech companies
Sign Up for FREE Below

Meet Your Presenter


Pradip K. Banerjee, Ph.D.

Chairman of the Board and Chief Executive Officer

Pradip K. Banerjee, Ph.D. is Xybion’s chairman of the board and chief executive officer. He is the founding Managing Partner (retired) of Accenture’s R&D Line of Business. He is an entrepreneurial senior executive with more than 30 years of in-depth experience in the global life sciences, healthcare and services industries in operations, strategic management, business development, investments and new venture creations. Previously, he held several R&D management positions at Abbott, Glaxo-Smith Kline and also served as president and CEO of the Science Center in Philadelphia.